Abstract:Background and objectives High-quality epidemiologic data on AKI in children are particularly lacking in developing countries. This study aimed to assess the epidemiology and clinical correlates of AKI among hospitalized children in China.Design, setting, participants, & measurements We performed a multicenter study, in a cohort of hospitalized children aged 1 month to 18 years, from 25 general and children's hospitals in China during 2013-2015. We obtained patient-level data from the electronic hospitalization information system and laboratory databases of all children who had at least two serum creatinine tests within any 7-day window during their first 30 days of hospitalization. We identified AKI events according to the creatinine criteria of Kidney Disease Improving Global Outcomes. The in-hospital outcomes of AKI, including mortality, kidney recovery, and length of stay, were assessed. We estimated the corresponding hazard ratios using a Cox proportional hazard model, with adjustment for age, sex, comorbidities, and clinical procedures.Results A total of 19,908 (20%) patients with AKI were identified among 101,836 pediatric inpatients, of which 7220 (7%) were community acquired and 12,688 (13%) were hospital acquired. Up to 96% of these AKI events were not diagnosed on the discharge records. The cumulative incidence of AKI in infants (28%) was twice that in adolescents (12%). The profiles of risk factors differed between community-acquired and hospital-acquired AM and varied with age. Diarrhea and sepsis were the top risk factors for community-acquired AM, each contributing 6% of the risk. Congenital heart disease/cardiac surgery was the major risk factor for hospital-acquired AM, contributing to 19% of cases. Exposure to nephrotoxic drugs, mostly nonsteroidal anti-inflammatory drugs and proton pump inhibitors, was common in hospitalized children and was associated with a higher risk of AM. Death occurred in 842 out of 19,908 patients (4%) with AM versus 450 out of 81,478 children (0.5%) without AM. The risk of in-hospital death was higher among children with severe AM, shock, and respiratory failure. Pediatric AM was associated with longer hospital stay and higher daily cost, even after adjustment for covariates.Conclusions Pediatric AKI is common and is substantially underdiagnosed in China.

Acid-Suppression Medications and the Risk of Hospital-Acquired Acute Kidney Injury in Children

Proton pump inhibitors and the risk of hospital-acquired acute kidney injury in children

Acid Suppression Use among Infants in One Tertiary Children's Hospital in China, 2015–2018: A Retrospective Observational Study

Acid-Suppressive Drugs and Risk of Fracture in Children and Young Adults: A Meta-Analysis of Observational Studies

Effect of proton pump inhibitors versus histamine-2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers

Acute kidney injury following the use of different proton pump inhibitor regimens: A real-world analysis of post-marketing surveillance data.

Nonsteroidal Anti-Inflammatory Drugs Associated Acute Kidney Injury in Hospitalized Children: A Systematic Review and Meta-Analysis

Association between Proton Pump Inhibitor Use and Risk of Incident Chronic Kidney Disease: Systematic Review and Meta-Analysis

The Association of Long-Term Use of Proton Pump Inhibitors and Histamine H2 Receptor Antagonists with Clinical Complications in Patients with Severe Sepsis

Acute Kidney Injury Among Hospitalized Children In China

Association between gastroprotective agents and acute kidney injury in patients receiving non-steroidal anti-inflammatory drugs: Analysis of a Japanese hospital-based database

The Efficacy And Safety Of Acid Suppressants For Gastrointestinal Bleeding Prophylaxis In Cardiac Care Unit Patients

Acid suppressants use and risk of atherosclerotic cardiovascular disease in middle-aged and older adults

Focus on Safety of Proton Pump Inhibitors

Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system

Proton Pump Inhibitors and Kidney Disease: An Intertwined Relationship

Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis

Acid-Suppressive Drug Use During Pregnancy and the Risk of Childhood Asthma: A Meta-analysis

Proton Pump Inhibitors in Children: the Good, the Bad, and the Ugly

Proton Pump Inhibitor Use and Worsening Kidney Function: A Retrospective Cohort Study Including 122,606 Acid-Suppressing Users

Association of Proton Pump Inhibitor Use and Immune Checkpoint Inhibitor Mediated Acute Kidney Injury: A Meta-Analysis and a Review of Related Outcomes